E3 ubiquitin ligase Casitas B lineage lymphoma-b and its potential therapeutic implications for immunotherapy

MLA

J Spoor, et al. “E3 Ubiquitin Ligase Casitas B Lineage Lymphoma-b and Its Potential Therapeutic Implications for Immunotherapy.” Clinical and Experimental Immunology, vol. 204, Jan. 2021, pp. 14–31. EBSCOhost, https://doi.org/10.1111/cei.13560.

APA

J Spoor, Davood Jafari, Leila Jafarzadeh, S Keshavarz Shahbaz, Safa Tahmasebi, Mohammad Javad Mousavi, & Abdolreza Esmaeilzadeh. (2021). E3 ubiquitin ligase Casitas B lineage lymphoma-b and its potential therapeutic implications for immunotherapy. Clinical and Experimental Immunology, 204, 14–31. https://doi.org/10.1111/cei.13560

Chicago

J Spoor, Davood Jafari, Leila Jafarzadeh, S Keshavarz Shahbaz, Safa Tahmasebi, Mohammad Javad Mousavi, and Abdolreza Esmaeilzadeh. 2021. “E3 Ubiquitin Ligase Casitas B Lineage Lymphoma-b and Its Potential Therapeutic Implications for Immunotherapy.” Clinical and Experimental Immunology 204 (January): 14–31. doi:10.1111/cei.13560.